Leo Ehrlich

Chief Executive Officer, Chief Financial Officer; Board Chairman

Mr. Ehrlich is a co-founder of Innovation Pharma and serves as Chief Financial Officer and Chief Executive Officer for the company. He also is Board Chairman. Mr. Ehrlich has over 25 years of executive leadership experience in building and managing emerging growth companies. Prior to joining Innovation, Mr. Ehrlich served as Chief Financial Officer and Director of Nanoviricides, a publicly-traded company developing nanotechnology-based antiviral medicines. Mr. Ehrlich also served in various management roles—as CEO, President, CFO, Director—while at StatSure Diagnostic Systems, Inc., a diagnostic specialty firm with a focus on HIV testing. Mr. Ehrlich is a Certified Public Accountant and received a BBA degree from Bernard Baruch College of the City University of New York. 

JANE HARNESS

Senior Vice President, Clinical Sciences and Portfolio Management

Ms. Harness is Senior Vice President, Clinical Sciences and Portfolio Management, for Innovation Pharma. Ms. Harness has over 20 years in domestic and international clinical drug development experience. Before joining Innovation, she served as Vice President, Clinical Operations, at Revance Therapeutics. Prior, she was the Head of Clinical Sciences, Dermatology and ATI Translational Research, at Novartis Institutes for Biomedical Research. Across fifteen years at Pfizer, she held the following notable positions: Global Clinical Lead, Inflammation and Immunology; Early Clinical Lead, Dermatology; and Clinical Trial Head and Process Improvement Lead, Experimental Medicine. Ms. Harness received a BS and MPhil (Protein Biochemistry) degree from University of Leicester, and a MSc (Clinical Pharmacology) from University of Aberdeen.